8 completed. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 8 |
Follow Melasma: new trials by email Literature Review of Melasma trials Research Report on Melasma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of New Trio Combination for Melasma New trio combination, Kligman's formula (trio) - Melasma | Phase 4 | Completed | Ghurki Trust and Teaching Hospital | 56 | 2025-05-07 | 2026-06-30 |
| Evaluation of an Herbal-Based De-Pigmenting System Herbal depigmenting agent (Epionce), Hydroquinone - Melasma, Hyperpigmentation | Phase 4 | Completed | Sadick Research Group | 28 | 2013-10-01 | 2015-11-18 |
| Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma 290-400 nm sunscreen, 290-800 nm sunscreen - Melasma | Phase 4 | Completed | Universidad Autonoma de San Luis Potosí | 68 | 2012-09-01 | 2014-12-02 |
| Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women 20-30% Salicylic Acid peels to the right side of the face, 20-30% Salicylic Acid peels to the left side of the face - Melasma | Phase 4 | Completed | University of Texas Southwestern Medical Center | 20 | 2008-01-01 | 2020-08-10 |
| Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid Jessner's solution chemical peel, Trichloroacetic acid chemical peel - Melasma | Phase 4 | Completed | Emory University | 19 | 2008-01-01 | 2013-11-14 |
| Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma Tri-Luma Maintenance regimen - Melasma | Phase 4 | Completed | Galderma R&D | 340 | 2006-11-01 | 2021-02-17 |
| Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma Fluocinolone acetonide 0.1%/hydroquinone 4%/tretinoin 0.05% Cream in sequence with glycolic acid peels - Melasma | Phase 4 | Completed | Galderma R&D | 20 | 2006-11-01 | 2022-07-29 |
| Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05% - Melasma | Phase 4 | Completed | Galderma R&D | 70 | 2006-05-01 | 2022-07-29 |
Melanosis (8) · Hyperpigmentation (1)
Pigmentation Disorders (8) · Skin Diseases (8) · Skin and Connective Tissue Diseases (8) · Hyperpigmentation (7)
hydroquinone (3) · Fluocinolone Acetonide (2) · Base Sequence (1) · Chemexfoliation (1) · Proto-Oncogene Proteins c-raf (1) · Shade UVAGuard (1) · Sunscreening Agents (1) · Tretinoin (1) · Zinc Oxide (1) · bis-ethylhexyloxyphenol methoxyphenyl triazine (1) · drometrizole trisiloxane (1) · ferric oxide (1) · octocrylene (1) · octyl triazone (1) · octylmethoxycinnamate (1)
Galderma R&D (3) · Emory University (1) · Ghurki Trust and Teaching Hospital (1) · Sadick Research Group (1) · Universidad Autonoma de San Luis Potosí (1) · University of Texas Southwestern Medical Center (1)
United States (5) · Mexico (2) · Brazil (1) · Pakistan (1)
Ronald W Gottschalk, MD (2) · Amit Pandya, M.D. (1) · Bertha Torres-Alvarez, MD (1) · Carl Washington, MD (1) · Diana Hernandez-Blanco, MD (1) · Dr Aliza Hamadani (1) · Dr. Ayesha Asad Chattha (1) · Dr. Iram Kausar (1) · Dr. Meshaal Azhar (1) · Juan P Castanedo-Cazares, MD (1) · Neil S Sadick, MD (1) · Prof. Dr. Haroon Nabi (1)